Skip to main content

Exforge FDA Approval History

FDA Approved: Yes (First approved June 20, 2007)
Brand name: Exforge
Generic name: amlodipine and valsartan
Dosage form: Tablets
Company: Novartis Pharmaceuticals Corporation
Treatment for: High Blood Pressure

Exforge is a single-tablet combination of an angiotensin receptor blocker (valsartan) and a calcium channel blocker (amlodipine) taken once-daily for the treatment of hypertension.

Development timeline for Exforge

DateArticle
Aug  4, 2008Approval Single-Pill Combinations Diovan HCT and Exforge Approved in US as First-Line Treatments for High Blood Pressure
Jun 21, 2007Approval Exforge Receives Final US Approval as New and Powerful TreatmentOption for Patients With High Blood Pressure
Apr 27, 2006US Submission of Exforge Accepted for Review by the FDA

See also

Exforge (amlodipine and valsartan) Consumer information

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer